Table 1.
Parameter | N | Sphere | Disk | Segmental | Irregular | p |
---|---|---|---|---|---|---|
All cases | 83 | 16 (19%) | 28 (34%) | 24 (29%) | 15 (18%) | |
DCIS2 | 8 | 0 | 4 (50%) | 4 (50%) | 0 | 0.15 |
Invasive | 75 | 16 (21%) | 24 (32%) | 20 (27%) | 15 (20%) | |
• IDC | 64 | 15 (23%) | 20 (31%) | 16 (25%) | 13 (20%) | 0.81 |
• ILC | 11 | 1 (9%) | 4 (36%) | 4 (25%) | 2 (13%) |
Table partially contains data previously published in prior publication materials (Barth, 2019, Ann Surg Oncol). Full permission to utilize the previously published dataset was obtained.
Abbrevations: DCIS, ductal carcinoma in situ ; IDC, invasive ductal carcinoma ; ILC, invasive lobular carcinoma ; ER(+), estrogen receptor positive; HER2(+), human epidermal growth factor receptor 2 positive